Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Shasun

Strides Shasun

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 25, 16:00
906.95
-42.3 (-4.46%)
VOLUME 46,007
LIVE
NSE
Sep 25, 15:52
904.75
-44.9 (-4.73%)
VOLUME 359,291
News on Strides Shasun
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Will be vertically integrated formulation company: Strides Shasun 

4.07 pm | 25 Sep 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Shashank Sinha, MD & GROUP CEO of Strides Shasun spoke about the latest happenings in his company and sector....

Strides Shasun up 3% on USFDA approval for Omega-3-Acid Ethyl Esters capsules

11.06 am | 20 Sep 2017 |  Source: Moneycontrol.com

NULL...

Strides Shasun receives USFDA approval for Omega-3-Acid Ethyl Esters capsules

10.41 am | 20 Sep 2017 |  Source: Moneycontrol.com

Strides Shasun has received approval from the USFDA approval for Omega-3-Acid Ethyl Esters capsules, a generic version of Lovaza....

Cabinet approves 78 days productivity-linked bonus for rail employees

7.33 am | 20 Sep 2017 |  Source: Moneycontrol.com

ITDC’s Hotel Jaipur Ashok and Lalitha Mahal Palace Hotel, Mysore is to be transferred to the Rajasthan and Karnataka government, respectively....

Strides Shasun: Outcome of AGM

4.16 pm | 15 Sep 2017 |  Source: Moneycontrol.com

Strides Shasun has informed about the outcome of AGM....

Buy Strides Shasun; target of Rs 1300: Motilal Oswal

3.48 pm | 14 Sep 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated Septemb...

Strides Shasun gets USFDA nod for kidney stone tablets

10.37 am | 12 Sep 2017 |  Source: PTI

In a BSE filing, Strides Shasun said it has received approval from the United States Food and Drug Administration (US FDA) for potassium citrate exten...

Strides Shasun gains 4% on USFDA approval for Potassium Citrate

9.26 am | 12 Sep 2017 |  Source: Moneycontrol.com

The company has received approval from the USFDA for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq and 15 mEq....

Strides Shasun receives USFDA approval for Potassium Citrate Extended-Release tablets

9.07 am | 12 Sep 2017 |  Source: Moneycontrol.com

Strides Shasun has received approval from the USFDA for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq and 15 mEq....

Stocks in the news: Tata Steel, Sun Pharma, ITC, Sobha, Liberty Shoes, Cochin Shipyard 

8.25 am | 12 Sep 2017 |  Source: CNBC-TV18

Tata Steel | Sun Pharma | ITC | Crest Ventures | JSW Steel | Sobha | Prestige Estates | InterGlobe Aviation | Liberty Shoes | Speciality Restaurants |...

Strides gets inspection report from USFDA for Bengaluru facility

11.28 am | 01 Sep 2017 |  Source: PTI

"The company's formulations facility (KRSG Gardens) in Bengaluru which was inspected by the USFDA in May 2017 has received the EIR, thereby confir...

Strides Shasun receives EIR from USFDA

9.36 am | 01 Sep 2017 |  Source: Moneycontrol.com

The company's formulations facility (KRSG Gardens) in Bengalore, which was inspected by the USFDA in May 2017, has received Establishment Inspecti...

Strides Shasun up 2% on EIR from USFDA for Bengalore unit

9.35 am | 01 Sep 2017 |  Source: Moneycontrol.com

The KRSG Gardens facility in Bangalore manufactures tablets, capsules, liquids, sachets, creams and ointments....

Strides Shasun's AGM held on September 15, 2017

8.15 pm | 24 Aug 2017 |  Source: Moneycontrol.com

We kindly want to inform you that the Annual General Meeting to be held on September 15, 2017....

These 10 pharma stocks’ PE trade at a discount of over 20% to 5-year average

9.40 am | 24 Aug 2017 |  Source: Moneycontrol.com

Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable v...

Buy Strides Shasun; target of Rs 1030: Axis Direct

4.49 pm | 22 Aug 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated August 18...

Buy Strides Shasun; target of Rs 1,200: Axis Direct

1.39 pm | 27 Jun 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1,200 in its research report dated Jun 22, ...

1 2
Quick Links for Strides Shasun
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.